Day: September 15, 2021

Mountain Valley MD Holdings Announces Voluntary Retraction of a Reported Data Set, No Material Change to Business Plan Anticipated

Mountain Valley MD Holdings Announces Voluntary Retraction of a Reported Data Set, No Material Change to Business Plan Anticipated

TORONTO, Sept. 15, 2021 (GLOBE NEWSWIRE) — Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (FRA: 20MP) announces an immediate voluntary retraction of the data contained in its news release dated December 10, 2020 with respect to its Ivectosol™ pre-clinical canine trial data, which was also referenced in a subsequent news release dated January 14, 2021. The Company has discovered errors in the results disclosed in the December 10, 2020 and January 14, 2021 news releases that were based on an erroneous analysis as well as the incorrect use of comparator data that should not have been applied to the pharmacokinetic analysis. The Company has immediately implemented corrective internal processes and has initiated steps to re-run the trial and will provide an update regarding the Ivectosol™ data package with the...

Continue reading

Cenovus announces Expiration and Results of Any and All Tender Offer

Cenovus announces Expiration and Results of Any and All Tender Offer

CALGARY, Alberta, Sept. 15, 2021 (GLOBE NEWSWIRE) — Cenovus Energy Inc. (TSX: CVE) (NYSE: CVE) today announced that its previously announced cash tender offer (the “Any and All Tender Offer”) for any and all of its outstanding 3.950% Notes due 2022 (the “3.950% Notes”) and 3.000% Notes due 2022 (the “3.000% Notes” and, together with the 3.950% Notes, the “Any and All Notes”) (CUSIP Nos. 448055AJ2 and 15135UAG4, respectively) expired at 5:00 p.m., New York City time, on September 15, 2021. According to information provided by D.F. King & Co., Inc., the tender and information agent for the Any and All Tender Offer, $252,644,000 aggregate principal amount of the 3.950% Notes and $294,017,000 aggregate principal amount of the 3.000% Notes were validly tendered and not validly withdrawn prior to or at the expiration of the Any...

Continue reading

Ayr Wellness Closes Acquisition of Garden State Dispensary

Ayr Wellness Closes Acquisition of Garden State Dispensary

MIAMI, Sept. 15, 2021 (GLOBE NEWSWIRE) — Ayr Wellness Inc. (CSE: AYR.A, OTC: AYRWF) (“Ayr” or the “Company”), a leading vertically integrated cannabis multi-state operator, today announced it has closed, through a wholly owned subsidiary, on the purchase of 100% of the membership interests of GSD NJ LLC (“Garden State Dispensary” or “GSD”), one of the 12 existing vertical permit holders in the State of New Jersey and one of the state’s original six alternative treatment centers (“ATCs”). GSD has three open dispensaries, the maximum allowed under its permit, at heavily trafficked highway locations throughout the central region of the state, as well as approximately 30,000 sq. ft. of operational cultivation and production facilities. An additional 75,000 sq. ft. of cultivation is under construction. “We are thrilled to be welcoming...

Continue reading

P2 Gold Announces Flow-Through Financing

P2 Gold Announces Flow-Through Financing

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTIONOR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES. VANCOUVER, British Columbia, Sept. 15, 2021 (GLOBE NEWSWIRE) — P2 Gold Inc. (“P2” or the “Company”) (TSX-V:PGLD) reports that it intends to complete a non-brokered private placement (the “Private Placement”) consisting of up to 1,000,000 flow-through common shares in the capital of the Company (the “Common Shares”) that qualify as flow-through shares for purposes of the Income Tax Act (Canada), at a price of $0.50 per Common Share for gross proceeds of up to $500,000. The gross proceeds of the Private Placement will be used to fund exploration expenditures on the BAM Property and for other Canadian Exploration Expenses that will qualify as “flow through...

Continue reading

Grom Social Enterprises, Inc. Closes $4.4 Million Private Placement

Grom Social Enterprises, Inc. Closes $4.4 Million Private Placement

Boca Raton, FL, Sept. 15, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Grom Social Enterprises, Inc. (NASDAQ:GROM) (“Grom” or the “Company”), the emerging social media and family entertainment company, today announced the closing of a $4.4 million private placement. The Investment is in the form of a 10% Original Issue Discount convertible note in the principal amount of $4,400,000 that has an 18-month maturity and a fixed conversion price of $4.20 per share of common stock, subject to adjustment, and warrants to purchase 813,278 shares of common stock with an exercise price of $4.20 per share, subject to adjustment. GROM is required to make monthly payments in either cash or shares, commencing 75 days after closing. GROM has agreed to file a registration statement registering for resale the shares of...

Continue reading

BioXcel Therapeutics Presents Results from Ongoing Phase 2 Trial of BXCL701 in Combination with KEYTRUDA® in Aggressive Forms of Prostate Cancer at ESMO

BioXcel Therapeutics Presents Results from Ongoing Phase 2 Trial of BXCL701 in Combination with KEYTRUDA® in Aggressive Forms of Prostate Cancer at ESMO

BXCL701 plus KEYTRUDA® (pembrolizumab) demonstrates encouraging anti-tumor activity in heavily pre-treated mCRPC patients with adenocarcinoma BXCL701 combination continues to exhibit favorable safety profile; patient enrollment continues as per protocol NEW HAVEN, Conn., Sept. 15, 2021 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced data from its ongoing Phase 1b/2 trial of BXCL701, the Company’s investigational, oral innate immunity activator, in metastatic castration-resistant prostate carcinoma (mCRPC) in a poster presentation at the 2021 European Society for Medical Oncology (ESMO) Congress. “These data lay a strong foundation for...

Continue reading

Diversey Announces Pricing of Senior Notes Offering

Diversey Announces Pricing of Senior Notes Offering

FORT MILL, S.C., Sept. 15, 2021 (GLOBE NEWSWIRE) — Diversey Holdings, Ltd. (NASDAQ: DSEY), a leading provider of hygiene, infection prevention and cleaning solutions, today announced that its indirect, wholly-owned subsidiary, Diamond (BC) B.V. (the “Company”) has priced the private placement of $500.0 million in aggregate principal amount of its 4.625% Senior Notes due 2029 (the “Notes”). The Notes will be issued under an indenture to be entered into upon the closing of the offering, which Diversey anticipates will take place on or about September 29, 2021, subject to customary closing conditions. Diversey intends to use the net proceeds from the offering to repay indebtedness and the remaining amount for general corporate matters and working capital purposes, including expenses relating to the transaction. The Notes will bear...

Continue reading

Billy Goat Brands to Commence Trading on the Canadian Securities Exchange on September 16, 2021

Billy Goat Brands to Commence Trading on the Canadian Securities Exchange on September 16, 2021

Investment Incubator Provides Exposure to High Growth Companies with an ESG Focus in the Blue Economy, Plant-Based Protein and Functional Food Industries VANCOUVER, British Columbia, Sept. 15, 2021 (GLOBE NEWSWIRE) — Billy Goat Brands Ltd. (the “Company” or “Billy Goat”) (CSE: GOAT), a venture capital platform focused on identifying, sponsoring and incubating environmental, social and governance (“ESG”) focused companies in the blue economy, is pleased to announce that its common shares will commence trading on the Canadian Securities Exchange (the “CSE”) on September 16, 2021, under the stock ticker symbol “GOAT”. To coincide with its listing on the CSE, Billy Goat has recently updated its website with new information about the Company and its investee businesses, including but not limited to a current investor presentation and...

Continue reading

Omega Flex, Inc. Announces Regular Quarterly Dividend for the Third Quarter 2021

Omega Flex, Inc. Announces Regular Quarterly Dividend for the Third Quarter 2021

EXTON, Pa., Sept. 15, 2021 (GLOBE NEWSWIRE) — Omega Flex, Inc. (the “Company”) (NASDAQ: OFLX) today announced that the Board of Directors declared a regular quarterly dividend of $0.30 per share payable on October 4, 2021 to shareholders of record on September 27, 2021. Kevin R. Hoben, the Company’s chairman stated that: “The commitment of Omega Flex, Inc. to its shareholders is reflected in part by the payment of this regular quarterly dividend. As the Company continues to emerge from this challenging time for the country and the economy, this dividend is the best indication of our belief in the Company’s ability to weather this storm.” In determining the amount of future regular quarterly dividends, the Board will review the cash needs of the Company, and based on results of operations, financial condition, capital expenditure...

Continue reading

Frank’s International N.V. Announces Voting Results and Merger Closing Timeline

Frank’s International N.V. Announces Voting Results and Merger Closing Timeline

HOUSTON, Sept. 15, 2021 (GLOBE NEWSWIRE) — Frank’s International N.V. (NYSE: FI) (the “Company” or “Frank’s”) today announced the results of its Annual General Meeting and plans for closing of the pending Expro merger. Highlights All proposals presented to shareholders were approved including the Expro merger proposal, which received over 90% support from voting shareholders. With all closing conditions now satisfied, the pending merger with Expro is scheduled to close on Friday, October 1, 2021. Frank’s will complete a reverse stock split with a ratio of 6-for-1 in conjunction with the closing of the merger. Michael Kearney, the Company’s Chairman, President and Chief Executive Officer, said,   “We are proud to announce the results of our shareholder vote last week which demonstrated significant shareholder support for the pending...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.